세계의 PDRN(Polydeoxyribonudeotide) : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Polydeoxyribonudeotide (PDRN) was estimated to be worth US$ 72.1 million in 2024 and is forecast to a readjusted size of US$ 540 million by 2031 with a CAGR of 32.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Polydeoxyribonudeotide (PDRN) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

PDRN is deoxyribonucleic acid(DNA) product, mainly comes from semen and roe of fish, rapidly repair injured scars. It can promote the collagen synthesis on the cell surface, reverse aging signs. PDRN is the excellent skin repair product widely used for both high-end beauty products and medical products. Strong functions of anti-radiation and shrinking pores, make skin appears brightly and elastically.

Polydeoxyribonucleotide (PDRN) and polynucleotide (PN) are regenerative materials extracted from the regenerative cell (sperm and testicle) gene segment (DNA) of salmon or trout. The molecular sizes of PDRN and PN are different (PN is bigger) and they are safe biogenic substances approved by the Ministry of Food and Drug Safety. PDRN are often used in pharmaceuticals for tissue regeneration and cornea regeneration as well as treatment and tissue restoration of wounds. PN is often used for medical devices (tissue regeneration) for skin regeneration, articular cartilage regeneration, and osteogenic tissues.

Both PDRN and PN are included in the report.

As a product of regenerative medicine, PDRN can synthesize DNA from damaged or hypoxic tissues, activate the regeneration of endogenous growth factors such as FGF, IGF, and EGF, accelerate cell metabolism, and improve skin repair and regeneration capabilities. The fiber network full of collagen and elastin can achieve skin rejuvenation, improve skin microenvironment, increase skin thickness, etc., so as to achieve the effect of improving problem skin.

The PDRN market has shown a significant growth trend in recent years, mainly driven by the field of regenerative medicine and tissue engineering, as well as the field of aesthetics. Demand for innovative solutions in medical fields such as wound healing, dermatology, orthopedics is driving the demand for PDRN products and therapies.

In terms of product types, freeze-dried powder occupies an important position, dominated with 65% market share in 2024, preferred for stability and versatility in pharmaceuticals and cosmetics. While PDRN Solutions are growing demand in injectables (e.g., mesotherapy), especially in Korea's "salmon needle" treatments. Expected to surge due to ease of clinical applicationAt the same time, in terms of application, the share of Medical Aesthetics (Mesotherapy) in 2024 is about 32%, used in "regenerative hydrogels" for collagen synthesis and anti-inflammatory effects.

The major global manufacturers of Polydeoxyribonudeotide (PDRN) include HTL Biotechnology, Ruijiming Biological, PharmaResearch Co., Ltd., Humedix, ReaLi Tide Biological, HENGYU BIOPH, Mastelli, Dongkook, BR PHARM, BMI KOREA, BNF Solution, etc. In 2024, the world's top three vendors accounted for approximately 56% of the revenue.

As a new type of regenerative material, PDRN has multiple activities such as promoting skin damage repair, anti-inflammatory, promoting angiogenesis, improving tissue microcirculation, etc. It has broad application prospects in the fields of medical devices, medicine, cosmetics, health foods, daily chemical products, medical cosmetology, etc. In the future, with the rise of medical beauty consumption and the expansion of application fields, the scale of the PDRN market will further expand. The PDRN market is poised for explosive growth, anchored by Asia-Pacific's dominance (Korea/China) and diversification into cosmetics/wound care. Key developments include China's regulatory openings, plant-based innovations, and the rise of "regenerative aesthetics."

This report aims to provide a comprehensive presentation of the global market for Polydeoxyribonudeotide (PDRN), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polydeoxyribonudeotide (PDRN) by region & country, by Type, and by Application.

The Polydeoxyribonudeotide (PDRN) market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polydeoxyribonudeotide (PDRN).

Market Segmentation

By Company

• HTL Biotechnology
• ReaLi Tide Biological
• PharmaResearch Co., Ltd.
• Humedix
• Ruijiming Biological
• Bloomage Biotech
• HENGYU BIOPH
• Mastelli
• Dongkook
• BR PHARM
• BNC Global
• BMI KOREA
• BNF Solution
• Nanjing Letop Biotechnology
• Topscience Biotech
• Freda Biotechnology
• Shebah Biotech
• APR Corporation
• Kolmar Korea
• PORIBIO INC.

Segment by Type

• Powder
• Solution

Segment by Application

• Mesotherapy
• Bone Injection & Dermal Fillers
• Pharmaceutical
• Cosmetic
• Wound Healing Products and Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Polydeoxyribonudeotide (PDRN) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Polydeoxyribonudeotide (PDRN) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Polydeoxyribonudeotide (PDRN) in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Polydeoxyribonudeotide (PDRN) Product Introduction
• 1.2 Global Polydeoxyribonudeotide (PDRN) Market Size Forecast
  • 1.2.1 Global Polydeoxyribonudeotide (PDRN) Sales Value (2020-2031)
  • 1.2.2 Global Polydeoxyribonudeotide (PDRN) Sales Volume (2020-2031)
  • 1.2.3 Global Polydeoxyribonudeotide (PDRN) Sales Price (2020-2031)
• 1.3 Polydeoxyribonudeotide (PDRN) Market Trends & Drivers
  • 1.3.1 Polydeoxyribonudeotide (PDRN) Industry Trends
  • 1.3.2 Polydeoxyribonudeotide (PDRN) Market Drivers & Opportunity
  • 1.3.3 Polydeoxyribonudeotide (PDRN) Market Challenges
  • 1.3.4 Polydeoxyribonudeotide (PDRN) Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Polydeoxyribonudeotide (PDRN) Players Revenue Ranking (2024)
• 2.2 Global Polydeoxyribonudeotide (PDRN) Revenue by Company (2020-2025)
• 2.3 Global Polydeoxyribonudeotide (PDRN) Players Sales Volume Ranking (2024)
• 2.4 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Company Players (2020-2025)
• 2.5 Global Polydeoxyribonudeotide (PDRN) Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Polydeoxyribonudeotide (PDRN) Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Polydeoxyribonudeotide (PDRN) Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Polydeoxyribonudeotide (PDRN)
• 2.9 Polydeoxyribonudeotide (PDRN) Market Competitive Analysis
  • 2.9.1 Polydeoxyribonudeotide (PDRN) Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Polydeoxyribonudeotide (PDRN) Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polydeoxyribonudeotide (PDRN) as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Powder
  • 3.1.2 Solution
• 3.2 Global Polydeoxyribonudeotide (PDRN) Sales Value by Type
  • 3.2.1 Global Polydeoxyribonudeotide (PDRN) Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Polydeoxyribonudeotide (PDRN) Sales Value, by Type (2020-2031)
  • 3.2.3 Global Polydeoxyribonudeotide (PDRN) Sales Value, by Type (%) (2020-2031)
• 3.3 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Type
  • 3.3.1 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Polydeoxyribonudeotide (PDRN) Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Polydeoxyribonudeotide (PDRN) Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Polydeoxyribonudeotide (PDRN) Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Mesotherapy
  • 4.1.2 Bone Injection & Dermal Fillers
  • 4.1.3 Pharmaceutical
  • 4.1.4 Cosmetic
  • 4.1.5 Wound Healing Products and Others
• 4.2 Global Polydeoxyribonudeotide (PDRN) Sales Value by Application
  • 4.2.1 Global Polydeoxyribonudeotide (PDRN) Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Polydeoxyribonudeotide (PDRN) Sales Value, by Application (2020-2031)
  • 4.2.3 Global Polydeoxyribonudeotide (PDRN) Sales Value, by Application (%) (2020-2031)
• 4.3 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Application
  • 4.3.1 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Polydeoxyribonudeotide (PDRN) Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Polydeoxyribonudeotide (PDRN) Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Polydeoxyribonudeotide (PDRN) Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Polydeoxyribonudeotide (PDRN) Sales Value by Region
  • 5.1.1 Global Polydeoxyribonudeotide (PDRN) Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Polydeoxyribonudeotide (PDRN) Sales Value by Region (2020-2025)
  • 5.1.3 Global Polydeoxyribonudeotide (PDRN) Sales Value by Region (2026-2031)
  • 5.1.4 Global Polydeoxyribonudeotide (PDRN) Sales Value by Region (%), (2020-2031)
• 5.2 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region
  • 5.2.1 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region (2020-2025)
  • 5.2.3 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region (2026-2031)
  • 5.2.4 Global Polydeoxyribonudeotide (PDRN) Sales Volume by Region (%), (2020-2031)
• 5.3 Global Polydeoxyribonudeotide (PDRN) Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
  • 5.4.2 North America Polydeoxyribonudeotide (PDRN) Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
  • 5.5.2 Europe Polydeoxyribonudeotide (PDRN) Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Polydeoxyribonudeotide (PDRN) Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
  • 5.7.2 South America Polydeoxyribonudeotide (PDRN) Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Polydeoxyribonudeotide (PDRN) Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Polydeoxyribonudeotide (PDRN) Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
  • 6.3.2 United States Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
  • 6.4.2 Europe Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
  • 6.5.2 China Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
  • 6.6.2 Japan Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
  • 6.7.2 South Korea Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Polydeoxyribonudeotide (PDRN) Sales Value, 2020-2031
  • 6.9.2 India Polydeoxyribonudeotide (PDRN) Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Polydeoxyribonudeotide (PDRN) Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 HTL Biotechnology
  • 7.1.1 HTL Biotechnology Company Information
  • 7.1.2 HTL Biotechnology Introduction and Business Overview
  • 7.1.3 HTL Biotechnology Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 HTL Biotechnology Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.1.5 HTL Biotechnology Recent Development
• 7.2 ReaLi Tide Biological
  • 7.2.1 ReaLi Tide Biological Company Information
  • 7.2.2 ReaLi Tide Biological Introduction and Business Overview
  • 7.2.3 ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 ReaLi Tide Biological Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.2.5 ReaLi Tide Biological Recent Development
• 7.3 PharmaResearch Co., Ltd.
  • 7.3.1 PharmaResearch Co., Ltd. Company Information
  • 7.3.2 PharmaResearch Co., Ltd. Introduction and Business Overview
  • 7.3.3 PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 PharmaResearch Co., Ltd. Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.3.5 PharmaResearch Co., Ltd. Recent Development
• 7.4 Humedix
  • 7.4.1 Humedix Company Information
  • 7.4.2 Humedix Introduction and Business Overview
  • 7.4.3 Humedix Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Humedix Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.4.5 Humedix Recent Development
• 7.5 Ruijiming Biological
  • 7.5.1 Ruijiming Biological Company Information
  • 7.5.2 Ruijiming Biological Introduction and Business Overview
  • 7.5.3 Ruijiming Biological Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Ruijiming Biological Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.5.5 Ruijiming Biological Recent Development
• 7.6 Bloomage Biotech
  • 7.6.1 Bloomage Biotech Company Information
  • 7.6.2 Bloomage Biotech Introduction and Business Overview
  • 7.6.3 Bloomage Biotech Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Bloomage Biotech Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.6.5 Bloomage Biotech Recent Development
• 7.7 HENGYU BIOPH
  • 7.7.1 HENGYU BIOPH Company Information
  • 7.7.2 HENGYU BIOPH Introduction and Business Overview
  • 7.7.3 HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 HENGYU BIOPH Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.7.5 HENGYU BIOPH Recent Development
• 7.8 Mastelli
  • 7.8.1 Mastelli Company Information
  • 7.8.2 Mastelli Introduction and Business Overview
  • 7.8.3 Mastelli Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Mastelli Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.8.5 Mastelli Recent Development
• 7.9 Dongkook
  • 7.9.1 Dongkook Company Information
  • 7.9.2 Dongkook Introduction and Business Overview
  • 7.9.3 Dongkook Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Dongkook Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.9.5 Dongkook Recent Development
• 7.10 BR PHARM
  • 7.10.1 BR PHARM Company Information
  • 7.10.2 BR PHARM Introduction and Business Overview
  • 7.10.3 BR PHARM Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 BR PHARM Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.10.5 BR PHARM Recent Development
• 7.11 BNC Global
  • 7.11.1 BNC Global Company Information
  • 7.11.2 BNC Global Introduction and Business Overview
  • 7.11.3 BNC Global Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 BNC Global Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.11.5 BNC Global Recent Development
• 7.12 BMI KOREA
  • 7.12.1 BMI KOREA Company Information
  • 7.12.2 BMI KOREA Introduction and Business Overview
  • 7.12.3 BMI KOREA Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 BMI KOREA Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.12.5 BMI KOREA Recent Development
• 7.13 BNF Solution
  • 7.13.1 BNF Solution Company Information
  • 7.13.2 BNF Solution Introduction and Business Overview
  • 7.13.3 BNF Solution Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 BNF Solution Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.13.5 BNF Solution Recent Development
• 7.14 Nanjing Letop Biotechnology
  • 7.14.1 Nanjing Letop Biotechnology Company Information
  • 7.14.2 Nanjing Letop Biotechnology Introduction and Business Overview
  • 7.14.3 Nanjing Letop Biotechnology Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Nanjing Letop Biotechnology Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.14.5 Nanjing Letop Biotechnology Recent Development
• 7.15 Topscience Biotech
  • 7.15.1 Topscience Biotech Company Information
  • 7.15.2 Topscience Biotech Introduction and Business Overview
  • 7.15.3 Topscience Biotech Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Topscience Biotech Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.15.5 Topscience Biotech Recent Development
• 7.16 Freda Biotechnology
  • 7.16.1 Freda Biotechnology Company Information
  • 7.16.2 Freda Biotechnology Introduction and Business Overview
  • 7.16.3 Freda Biotechnology Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 Freda Biotechnology Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.16.5 Freda Biotechnology Recent Development
• 7.17 Shebah Biotech
  • 7.17.1 Shebah Biotech Company Information
  • 7.17.2 Shebah Biotech Introduction and Business Overview
  • 7.17.3 Shebah Biotech Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.17.4 Shebah Biotech Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.17.5 Shebah Biotech Recent Development
• 7.18 APR Corporation
  • 7.18.1 APR Corporation Company Information
  • 7.18.2 APR Corporation Introduction and Business Overview
  • 7.18.3 APR Corporation Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.18.4 APR Corporation Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.18.5 APR Corporation Recent Development
• 7.19 Kolmar Korea
  • 7.19.1 Kolmar Korea Company Information
  • 7.19.2 Kolmar Korea Introduction and Business Overview
  • 7.19.3 Kolmar Korea Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.19.4 Kolmar Korea Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.19.5 Kolmar Korea Recent Development
• 7.20 PORIBIO INC.
  • 7.20.1 PORIBIO INC. Company Information
  • 7.20.2 PORIBIO INC. Introduction and Business Overview
  • 7.20.3 PORIBIO INC. Polydeoxyribonudeotide (PDRN) Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.20.4 PORIBIO INC. Polydeoxyribonudeotide (PDRN) Product Offerings
  • 7.20.5 PORIBIO INC. Recent Development

8 Industry Chain Analysis

• 8.1 Polydeoxyribonudeotide (PDRN) Industrial Chain
• 8.2 Polydeoxyribonudeotide (PDRN) Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Polydeoxyribonudeotide (PDRN) Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Polydeoxyribonudeotide (PDRN) Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer